Overview

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
This study aim to compare the efficacy, safety and quality of life of vinflunine/gemcitabine and carboplatin/gemcitabine in patients with metastatic urothelial cancer and impaired renal function.
Phase:
Phase 2
Details
Lead Sponsor:
Dr Anders Ullén
Treatments:
Carboplatin
Gemcitabine
Vinblastine